Ehrenkranz R A, Bonta B W, Ablow R C, Warshaw J B
N Engl J Med. 1978 Sep 14;299(11):564-9. doi: 10.1056/NEJM197809142991102.
We studied the effect of vitamin E on the development of bronchopulmonary dysplasis in neonates with respiratory-distress syndrome. Twenty infants received vitamin E administered intramuscularly during the acute phase of the syndrome, and 20 infants served as controls. Administration of vitamin E significantly increased the serum vitamin E concentration. Nine vitamin-treated and 13 control patients required supplemental oxygen for longer than 250 hours; all were treated with positive-pressure ventilation and endotracheal continuous distending airway pressure. Six of those 13 controls had x-ray changes consistent with bronchopulmonary dysplasia, and four died. None of the nine vitamin-treated patients had changes characteristic of bronchopulmonary dysplasia (P = 0.046), and all survived. Administration of vitamin E during the acute phase of the respiratory-distress syndrome appears to modify the development of bronchopulmonary dysplasis.
我们研究了维生素E对患有呼吸窘迫综合征的新生儿支气管肺发育不良发展的影响。20名婴儿在该综合征急性期接受了肌肉注射维生素E治疗,另有20名婴儿作为对照。维生素E的给药显著提高了血清维生素E浓度。9名接受维生素治疗的患者和13名对照患者需要补充氧气超过250小时;所有患者均接受了正压通气和气管内持续气道扩张压治疗。13名对照患者中有6名出现了与支气管肺发育不良一致的X线改变,4名死亡。9名接受维生素治疗的患者中无一出现支气管肺发育不良的特征性改变(P = 0.046),且全部存活。在呼吸窘迫综合征急性期给予维生素E似乎可改变支气管肺发育不良的发展。